Who is Pine Pharmaceuticals?

Pine Pharmaceuticals provides pharmaceutical compounding, including specialized sterile formulations serving ophthalmologists, retinal specialists, hospitals, medical practices and clinics. Their sterile compounded preparations are made to order and formulated using cutting edge technology and industry-leading quality assurance practices. Pine Pharmaceuticals has been committed to delivering the highest quality compounded products for over 30 years. They are committed to operating in compliance with current Good Manufacturing Practices (cGMP), thus providing customers with the peace of mind with every order. In a new state-of-the-art facility, Pine Pharmaceuticals was designed from the ground up to comply with FDA’s cGMP. The facility design is an essential component to being capable of preparing the highest quality products and is located in Tonawanda, New York.

Business Challenges

  • Disparate systems which did not connect to each other
  • Manual quality system and inventory processes
  • Lack of integrated solution to mitigate FDA compliance risk
  • Need for system to meet current Good Manufacturing Practices (cGMP)


  • Pine will be moving away from their manual quality system and inventory processes to an automated system
  • The ERP system will help to increase efficiency and accelerate business processes while putting in place a solution that helps them meet strict FDA requirements
  • They have implemented the Copley FDA Extended ERP Solution based on Infor CSI to automate all processes and accelerate the growth of their organization


“We had a number of different systems in place that required very manual processes to get the information required.” With the continued growth of our company we needed to have a solution in place that could improve our processes to support this growth, while also helping us meet FDA requirements. With Copley we have the support we need to get the solution up and running to automate all of our processes and accelerate the recent success we’ve had here at Pine.”

Alfonse J. Muto,
President of Pine Pharmaceuticals